FDA.reportPublic FDA data

inclisiran 284 MG in 1.5 ML Prefilled Syringe

RxCUI
2588263
RxNorm name
inclisiran 284 MG in 1.5 ML Prefilled Syringe
Display name
inclisiran 284 MG in 1.5 ML Prefilled Syringe
Full name
inclisiran 284 MG in 1.5 ML Prefilled Syringe
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LEQVIOINCLISIRANNovartis Pharmaceuticals Corporation6fc0afca-4513-4c35-b594-6544aee29a442026-08-19Warnings, Adverse reactionsExact identifier
rxcui: 2588263

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6fc0afca-4513-4c35-b594-6544aee29a44inclisiran 284 MG in 1.5 ML Prefilled Syringe [PSN] · 1.5 ML inclisiran 189 MG/ML Prefilled Syringe [SCD] · inclisiran 284 MG per 1.5 ML Prefilled Syringe [SY]312These highlights do not include all the information needed to use LEQVIO safely and effectively. See full prescribing information for LEQVIO. LEQVIO ® (inclisiran) injection, for subcutaneous use Initial U.S. Approval: 202120260212